Chronic Refractory Cough

Brief description of study

Detailed Study Description

A double-blind, randomized, placebo-controlled study of the efficacy and safety of three doses of Orvepitant in subjects with chronic refractory cough.

Clinical Study Identifier: TX82223

Start Over

Cherish Semeski

Vital Prospects Clinical Research Institute, P.C.

Tulsa, OK USA

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up today »

Powered by

Chronic Refractory Cough

Brief description of study

Detailed Study Description

Enter your location

Cherish Semeski

Receive Emails About New Clinical Trials!